rs397516940
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_004415.4(DSP):c.4531C>T(p.Gln1511Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004415.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSP | NM_004415.4 | c.4531C>T | p.Gln1511Ter | stop_gained | 23/24 | ENST00000379802.8 | NP_004406.2 | |
DSP | NM_001008844.3 | c.3582+949C>T | intron_variant | NP_001008844.1 | ||||
DSP | NM_001319034.2 | c.4050+481C>T | intron_variant | NP_001305963.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSP | ENST00000379802.8 | c.4531C>T | p.Gln1511Ter | stop_gained | 23/24 | 1 | NM_004415.4 | ENSP00000369129 | P2 | |
DSP | ENST00000418664.2 | c.3582+949C>T | intron_variant | 1 | ENSP00000396591 | A2 | ||||
DSP | ENST00000710359.1 | c.4050+481C>T | intron_variant | ENSP00000518230 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249842Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135242
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461694Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727138
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152132Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74326
ClinVar
Submissions by phenotype
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | May 31, 2023 | This variant changes 1 nucleotide in exon 23 of the DSP gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been reported in two unrelated individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 26569459, 31386562), in one individual affected with dilated cardiomyopathy (PMID: 31317183), and in one individual suspected of having hereditary cardiomyopathies (PMID: 35083019). This variant has been identified in 5/249842 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of DSP function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. - |
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 22, 2023 | This variant is present in population databases (rs397516940, gnomAD 0.05%). This sequence change creates a premature translational stop signal (p.Gln1511*) in the DSP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DSP are known to be pathogenic (PMID: 20716751, 24503780, 25227139). This premature translational stop signal has been observed in individual(s) with arrhythmogenic right ventricular cardiomyopathy (PMID: 31386562). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 44914). - |
Arrhythmogenic right ventricular cardiomyopathy Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 23, 2015 | The p.Gln1511X variant in DSP has been previously identified by our laboratory i n 1 adult with features of HCM and ARVC as well as right bundle branch block (RB BB). It has also been identified in 4/65986 European chromosomes by the Exome Ag gregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs397516940). This nonsense variant leads to a premature termination codon at position 1511, w hich is predicted to lead to a truncated or absent protein. Frameshift and nonse nse variants in DSP have been well reported in patients with ARVC (http://arvcda tabase.info/), but recent evidence supports that they can also cause DCM (Pugh 2 014). In summary, although additional studies are required to fully establish it s clinical significance, the p.Gln1511X variant is likely pathogenic. - |
Cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 23, 2023 | This variant changes 1 nucleotide in exon 23 of the DSP gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been reported in two unrelated individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 26569459, 31386562), in one individual affected with dilated cardiomyopathy (PMID: 31317183), and in one individual suspected of having hereditary cardiomyopathies (PMID: 35083019). This variant has been identified in 5/249842 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Loss of DSP function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 28, 2022 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31317183, 31402444, 32372669, 31386562, 26569459, 33460606, 34352074) - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2022 | The p.Q1511* pathogenic mutation (also known as c.4531C>T), located in coding exon 23 of the DSP gene, results from a C to T substitution at nucleotide position 4531. This changes the amino acid from a glutamine to a stop codon within coding exon 23. This alteration has been associated in the literature with cardiovascular disease (Akdis D et al. Heart Rhythm, 2016 Mar;13:731-41; van Lint FHM et al. Circ Genom Precis Med, 2019 08;12:e002467; Augusto JB et al. Eur Heart J Cardiovasc Imaging, 2020 03;21:326-336; Reza N et al. Cardiogenetics, 2022 Mar;12:24-36). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Alterations in DSP that result in haploinsufficiency or protein truncation have been reported in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and dilated cardiomyopathy (DCM) (Fressart V et al. Europace. 2010;12(6):861-8; Elliott P et al. Circ Cardiovasc Genet. 2010;3(4):314-22; Quarta G et al. Circulation. 2011;123(23):2701-9; Garcia-Pavia P et al. Heart. 2011;97(21):1744-52; Rasmussen TB et al. Clin Genet. 2013;84(1):20-30; Pugh TJ et al. Genet Med. 2014;16(8):601-8). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at